Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
- 1 March 1994
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 45 (3) , 890-896
- https://doi.org/10.1038/ki.1994.117
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Gene expression of interleukin-1β during hemodialysisKidney International, 1993
- Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infectionClinical and Experimental Immunology, 1992
- Cytokines: Agents provocateurs in hemodialysis?Kidney International, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Elevated circulating levels of interleukin-6 in patients with chronic renal failureKidney International, 1991
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- Differences in the synthesis and kinetics of release of interleukin 1α, interleukin 1β and tumor necrosis factor from human mononuclear cellsEuropean Journal of Immunology, 1989
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Induction of Tumor Necrosis Factor during Extracorporeal Blood PurificationNew England Journal of Medicine, 1987
- Hemodialysis Hypotension: The Interleukin HypothesisBlood Purification, 1983